AAAAAA
Results:
1-13
|
Results: 13
Authors:
WYATT LS
CARROLL MW
CZERNY CP
MERCHLINSKY M
SISLER JR
MOSS B
Citation: Ls. Wyatt et al., MARKER RESCUE OF THE HOST-RANGE RESTRICTION DEFECTS OF MODIFIED VACCINIA VIRUS ANKARA, Virology (New York, N.Y. Print), 251(2), 1998, pp. 334-342
Authors:
SETH A
OURMANOV I
KURODA MJ
SCHMITZ JE
CARROLL MW
WYATT LS
MOSS B
FORMAN MA
HIRSCH VM
LETVIN NL
Citation: A. Seth et al., RECOMBINANT MODIFIED VACCINIA VIRUS ANKARA-SIMIAN IMMUNODEFICIENCY VIRUS GAG POL ELICITS CYTOTOXIC T-LYMPHOCYTES IN RHESUS-MONKEYS DETECTEDBY A MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I PEPTIDE TETRAMER, Proceedings of the National Academy of Sciences of the United Statesof America, 95(17), 1998, pp. 10112-10116
Authors:
OVERWIJK WW
TSUNG A
IRVINE KR
PARKHURST MR
GOLETZ TJ
TSUNG K
CARROLL MW
LIU CL
MOSS B
ROSENBERG SA
RESTIFO NP
Citation: Ww. Overwijk et al., GP100 PMEL-17 IS A MURINE TUMOR REJECTION ANTIGEN - INDUCTION OF SELF-REACTIVE, TUMORICIDAL T-CELLS USING HIGH-AFFINITY, ALTERED PEPTIDE LIGAND/, The Journal of experimental medicine, 188(2), 1998, pp. 277-286
Authors:
CARROLL MW
MOSS B
Citation: Mw. Carroll et B. Moss, POXVIRUSES AS EXPRESSION VECTORS, Current opinion in biotechnology, 8(5), 1997, pp. 573-577
Authors:
CARROLL MW
OVERWIJK WW
CHAMBERLAIN RS
ROSENBERG SA
MOSS B
RESTIFO NP
Citation: Mw. Carroll et al., HIGHLY ATTENUATED MODIFIED VACCINIA VIRUS ANKARA (MVA) AS AN EFFECTIVE RECOMBINANT VECTOR - A MURINE TUMOR-MODEL, Vaccine, 15(4), 1997, pp. 387-394
Authors:
YANG ST
CARROLL MW
TORRESDUARTE AP
MOSS B
DAVIDSON EA
Citation: St. Yang et al., ADDITION OF THE MSA1 SIGNAL AND ANCHOR SEQUENCES TO THE MALARIA MEROZOITE SURFACE-ANTIGEN-1 C-TERMINAL REGION ENHANCES IMMUNOGENICITY WHEN EXPRESSED BY RECOMBINANT VACCINIA VIRUS, Vaccine, 15(12-13), 1997, pp. 1303-1313
Authors:
CARROLL MW
MOSS B
Citation: Mw. Carroll et B. Moss, HOST-RANGE AND CYTOPATHOGENICITY OF THE HIGHLY ATTENUATED MVA STRAIN OF VACCINIA VIRUS - PROPAGATION AND GENERATION OF RECOMBINANT VIRUSES IN A NONHUMAN MAMMALIAN-CELL LINE, Virology, 238(2), 1997, pp. 198-211
Authors:
BRONTE V
CARROLL MW
GOLETZ TJ
WANG M
OVERWIJK WW
MARINCOLA F
ROSENBERG SA
MOSS B
RESTIFO NP
Citation: V. Bronte et al., ANTIGEN EXPRESSION BY DENDRITIC CELLS CORRELATES WITH THE THERAPEUTICEFFECTIVENESS OF A MODEL RECOMBINANT POXVIRUS TUMOR VACCINE, Proceedings of the National Academy of Sciences of the United Statesof America, 94(7), 1997, pp. 3183-3188
Authors:
HIRSCH VM
FUERST TR
SUTTER G
CARROLL MW
YANG LC
GOLDSTEIN S
PIATAK M
ELKINS WR
ALVORD WG
MONTEFIORI DC
MOSS B
LIFSON JD
Citation: Vm. Hirsch et al., PATTERNS OF VIRAL REPLICATION CORRELATE WITH OUTCOME IN SIMIAN IMMUNODEFICIENCY VIRUS (SIV)-INFECTED MACAQUES - EFFECT OF PRIOR IMMUNIZATION WITH A TRIVALENT SIV VACCINE IN MODIFIED VACCINIA VIRUS ANKARA, Journal of virology, 70(6), 1996, pp. 3741-3752
Authors:
RAO JB
CHAMBERLAIN RS
BRONTE V
CARROLL MW
IRVINE KR
MOSS B
ROSENBERG SA
RESTIFO NP
Citation: Jb. Rao et al., IL-12 IS AN EFFECTIVE ADJUVANT TO RECOMBINANT VACCINIA VIRUS-BASED TUMOR VACCINES - ENHANCEMENT BY SIMULTANEOUS B7-1 EXPRESSION, The Journal of immunology, 156(9), 1996, pp. 3357-3365
Authors:
CARROLL MW
Citation: Mw. Carroll, WHEN CONGRESS JUST SAYS NO - DETERRENCE THEORY AND THE INADEQUATE ENFORCEMENT OF THE FEDERAL-ELECTION CAMPAIGN ACT, The Georgetown law journal, 84(3), 1996, pp. 551-588
Authors:
CHAMBERLAIN RS
CARROLL MW
BRONTE V
HWU P
WARREN S
YANG JC
NISHIMURA M
MOSS B
ROSENBERG SA
RESTIFO NP
Citation: Rs. Chamberlain et al., COSTIMULATION ENHANCES THE ACTIVE IMMUNOTHERAPY EFFECT OF RECOMBINANTANTICANCER VACCINES, Cancer research, 56(12), 1996, pp. 2832-2836
Authors:
CARROLL MW
MOSS B
Citation: Mw. Carroll et B. Moss, ESCHERICHIA-COLI BETA-GLUCURONIDASE (GUS) AS A MARKER FOR RECOMBINANTVACCINIA VIRUSES, BioTechniques, 19(3), 1995, pp. 352
Risultati:
1-13
|